Provided by Tiger Trade Technology Pte. Ltd.

Corgi NVO 2x Daily ETF

17.47
-0.6390-3.53%
Volume:132
Turnover:2K
Market Cap:262.02K
PE:- -
High:17.47
Open:17.37
Low:17.37
Close:18.11
52wk High:27.19
52wk Low:17.37
Shares:15.00K
Float Shares:15.00K
Volume Ratio:8.92
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

After Ozempic, Novo Nordisk Bets On Anthropic—While Pharma Still Awaits AI's First Approved Drug

Bellwether Stocks Movement
·
7 hours ago

Sector Update: Healthcare

MT Newswires Live
·
13 hours ago

Will AI Save the Pharma Industry Billions? Novo's Anthropic Deal is Betting on It.

Dow Jones
·
16 hours ago

Novo Nordisk Will Use Anthropic's Claude for Drug Research

Dow Jones
·
16 hours ago

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
16 hours ago

Novo Nordisk announces collaboration with Anthropic

TIPRANKS
·
Yesterday

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

Novo CEO Urges Staff to Embrace More Customer-Focused Culture

Reuters
·
Sep 15

Sector Update: Healthcare

MT Newswires Live
·
Sep 15

Novo Nordisk Stock (NVO) Is Falling Despite Rebrand to ‘Novo’ — Here’s Why

TIPRANKS
·
Sep 15

Lilly: Foundayo Has Captured Over 30% Of New Patient Share In The U.S. Oral Weight-Loss Drug Market

Bellwether Stocks Movement
·
Sep 15

Novo Nordisk rebranding as ‘Novo,’ announces cultural reset

TIPRANKS
·
Sep 15

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
Sep 15

Lilly's Foundayo Grabs 30% Of New U.S. Orforglipron Patients, Chipping Away At Novo's Head Start

Options & Short Sell
·
Sep 15

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Sep 15

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
Sep 15

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

Novo Nordisk Kept at Hold as Analyst Maintains $47 Price Target Amid Strategic Uncertainty

TIPRANKS
·
Sep 14

Data Retention Terms Prompt Restraints on AI Model Use for Sensitive Operations

Deep News
·
Sep 14